Manus Neurodynamica (“Manus” and “the Company”) is radically innovating health care management in the emerging field of diagnostics for neuromotor impairments, initially in Parkinson's Disease (PD). Our principal product, the Neuromotor Penℱ for the diagnosis and monitoring of neuromotor impairments, is a non-invasive, patented technology that records and analyses limb and hand motion to assess the underlying neuromotor processes, particularly for patients with PD.